摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Methyl-5-phenyl-4-hydroxy-1,2,3-triazol | 23233-12-7

中文名称
——
中文别名
——
英文名称
1-Methyl-5-phenyl-4-hydroxy-1,2,3-triazol
英文别名
1-methyl-5-phenyl-1,5-dihydro-[1,2,3]triazol-4-one;1-Methyl-5-phenyltriazol-4-ol
1-Methyl-5-phenyl-4-hydroxy-1,2,3-triazol化学式
CAS
23233-12-7
化学式
C9H9N3O
mdl
——
分子量
175.19
InChiKey
CAFOLHGKSOWOEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    50.9
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS
    申请人:Donahue Frances Anne
    公开号:US20100056520A1
    公开(公告)日:2010-03-04
    The present invention is directed to formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA 2 , compositions containing the same and processes for manufacture thereof.
  • US7713964B2
    申请人:——
    公开号:US7713964B2
    公开(公告)日:2010-05-11
  • [EN] LIQUID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS<br/>[FR] INHIBITEURS DE L'ENZYME PHOSPHOLIPASE SOUS FORME DE PRÉPARATIONS LIQUIDES
    申请人:WYETH CORP
    公开号:WO2008055136A2
    公开(公告)日:2008-05-08
    [EN] The present invention relates to liquid formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.
    [FR] Préparations liquides d'inhibiteurs des enzymes phospholipases tels que le PLA2 cytosolique, compositions renfermant ces préparations et procédés de fabrication correspondants.
  • [EN] FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS<br/>[FR] FORMULATIONS D'INHIBITEURS D'ENZYMES PHOSPHOLIPASE
    申请人:WYETH CORP
    公开号:WO2008055146A2
    公开(公告)日:2008-05-08
    (EN) The present invention is directed to formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.(FR) La présente invention concerne des formulations d'inhibiteurs d'enzymes phospholipase, telles que des compositions PLA2 cytosoliques les contenant et leurs procédés de fabrication.
  • [EN] SEMI-SOLID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS<br/>[FR] FORMULATIONS DEMI-SOLIDES D'INHIBITEURS DE L'ENZYME PHOSPHOLIPASE
    申请人:WYETH CORP
    公开号:WO2008055148A2
    公开(公告)日:2008-05-08
    [EN] The present invention is directed to semi-solid formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.
    [FR] La présente invention porte sur des formulations demi-solides d'inhibiteurs d'enzymes phospholipases, telles que le PLA2 cytosolique, sur des compositions les contenant, et sur des procédés de fabrication de celles-ci.
查看更多